E-Rui Biotech announced that Yirui Venture Capital, the controlling shareholder of the company, and its co-actors, E-Carrey, reduced their holdings of the company's shares by a total of 3.3 million shares through bulk transactions, accounting for 0.8147% of the company's total share capital. After this change in equity, the controlling shareholder Yirui Venture Capital, the actual controller Zhu Hai, and their co-actors dropped their total shares from 57.7992% to 56.9845%. The change hit an integer multiple of 1%.

E-Rui Biotech announced that Yirui Venture Capital, the controlling shareholder of the company, and its co-actors, E-Carrey, reduced their holdings of the company's shares by a total of 3.3 million shares through bulk transactions, accounting for 0.8147% of the company's total share capital. After this change in equity, the controlling shareholder Yirui Venture Capital, the actual controller Zhu Hai, and their co-actors dropped their total shares from 57.7992% to 56.9845%. The change hit an integer multiple of 1%.